Avalo Therapeutics (AVTX) Short Interest Ratio & Short Volume $4.88 +0.17 (+3.61%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Short Interest DataAvalo Therapeutics (AVTX) has a short interest of 46,900 shares, representing 0.54% of the float (the number of shares available for trading by the public). This marks a -45.78% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 58,944 shares to cover all short positions.Current Short Interest46,900 sharesPrevious Short Interest86,500 sharesChange Vs. Previous Month-45.78%Dollar Volume Sold Short$185.26 thousandShort Interest Ratio0.5 Days to CoverLast Record DateMay 31, 2025Outstanding Shares10,828,000 sharesFloat Size8,610,000 sharesShort Percent of Float0.54%Today's Trading Volume46,938 sharesAverage Trading Volume58,944 sharesToday's Volume Vs. Average80% Short Selling Avalo Therapeutics? Sign up to receive the latest short interest report for Avalo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVTX Short Interest Over TimeAVTX Days to Cover Over TimeAVTX Percentage of Float Shorted Over Time Avalo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202546,900 shares $185.26 thousand -45.8%0.5%0.5 $3.95 5/15/202586,500 shares $333.89 thousand +90.1%1.0%1.1 $3.86 4/30/202545,500 shares $226.59 thousand -54.7%0.5%0.7 $4.98 4/15/2025100,400 shares $491.96 thousand -13.2%1.2%1.4 $4.90 3/31/2025115,700 shares $926.76 thousand +20.3%1.4%1.6 $8.01 3/15/202596,200 shares $710.92 thousand +6.2%1.1%1 $7.39 2/28/202590,600 shares $662.29 thousand +19.2%1.1%0.9 $7.31 2/15/202576,000 shares $558.60 thousand +75.5%0.9%0.9 $7.35 1/31/202543,300 shares $364.59 thousand -22.4%0.5%0.5 $8.42 1/15/202555,800 shares $352.66 thousand +176.2%0.7%0.6 $6.32 Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202420,200 shares $150.09 thousand -11.8%0.2%0.2 $7.43 12/15/202422,900 shares $211.37 thousand +340.4%0.3%0.3 $9.23 11/30/20245,200 shares $49.66 thousand -46.9%0.1%0.1 $9.55 11/15/20249,800 shares $121.62 thousand -3.0%0.1%0.3 $12.41 10/31/202410,100 shares $131.40 thousand -79.5%0.1%0.4 $13.01 10/15/202449,200 shares $476.75 thousand -9.2%0.5%2.6 $9.69 9/30/202454,200 shares $514.90 thousand -8.9%0.6%3.1 $9.50 9/15/202459,500 shares $534.31 thousand +38.1%0.6%3.7 $8.98 8/31/202443,100 shares $301.70 thousand -23.6%5.0%2.4 $7.00 8/15/202456,400 shares $522.26 thousand -3.8%5.8%3.9 $9.26 7/31/202458,600 shares $666.87 thousand -9.6%6.0%3 $11.38 7/15/202464,800 shares $793.80 thousand -13.5%6.6%2.1 $12.25 6/30/202474,900 shares $934.00 thousand -0.7%7.7%1.4 $12.47 6/15/202475,400 shares $824.12 thousand -7.8%N/A0.1 $10.93 5/31/202481,800 shares $955.83 thousand -1.6%N/A0.1 $11.69 5/15/202483,100 shares $863.41 thousand -20.3%N/A0.1 $10.39 4/30/2024104,300 shares $1.79 million -32.0%N/A0.2 $17.12 4/15/2024153,400 shares $2.34 million +95.4%N/A0.2 $15.24 3/31/202478,500 shares $1.71 million +16.8%N/A0.1 $21.75 3/15/202467,200 shares $293.66 thousand +10.3%N/A1.3 $4.37 2/29/202460,900 shares $268.57 thousand -4.8%N/A0.7 $4.41 2/15/202464,000 shares $304.64 thousand -21.3%N/A0.7 $4.76 1/31/202481,300 shares $378.05 thousand -4.0%N/A0.8 $4.65 1/15/202484,700 shares $484.48 thousand +32.1%N/A0.7 $5.72 12/31/202364,100 shares $583.31 thousand -99.5%N/A0.4 $9.10 12/15/202312,640,000 shares $758.40 thousand +23.8%N/A0.2 $0.06 11/30/202310,210,000 shares $713.68 thousand -43.7%N/A0.1 $0.07 11/15/202318,140,000 shares $1.79 million +40.8%N/A0.2 $0.10 10/31/202312,880,000 shares $1.41 million +3.5%N/A0.2 $0.11 10/15/202312,450,000 shares $1.85 million -29.1%N/A0.2 $0.15The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 9/30/202317,550,000 shares $2.12 million +471.7%90.2%0.3 $0.12 9/15/20233,070,000 shares $406.78 thousand +220.1%15.8%0.1 $0.13 8/31/2023959,000 shares $95.90 thousand +0.2%5.2%0.1 $0.10 8/15/2023957,300 shares $134.02 thousand -10.5%5.2%0.2 $0.14 7/31/20231,070,000 shares $214 thousand +20.6%5.8%0.6 $0.20 7/15/2023887,000 shares $294.57 thousand +41.2%7.4%0.7 $0.33 6/30/2023628,400 shares $223.21 thousand +1,528.0%5.3%0.6 $0.36 6/15/202338,600 shares $145.33 thousand -9.4%0.4%0.1 $3.77 5/31/202342,600 shares $122.26 thousand -2.7%0.4%0.6 $2.87 5/15/202343,800 shares $120.45 thousand +17.1%0.4%0.9 $2.75 4/30/202337,400 shares $108.83 thousand -23.8%0.3%1.2 $2.91 4/15/202349,100 shares $127.66 thousand +172.8%0.4%1.7 $2.60 3/31/202318,000 shares $31.50 thousand -3.7%0.2%0.7 $1.75 3/15/202318,700 shares $46.84 thousand -24.6%0.2%1.1 $2.51 2/28/202324,800 shares $62.50 thousand +30.5%0.4%1.6 $2.52 2/15/202319,000 shares $56.24 thousand -32.4%0.3%1.3 $2.96 1/31/202328,100 shares $110.71 thousand -30.8%0.3%1.7 $3.94 1/15/202340,600 shares $197.32 thousand +17.0%0.5%2.7 $4.86 12/30/202234,700 shares $174.89 thousand -15.0%0.4%2.4 $5.04 12/15/202240,800 shares $237.86 thousand +9.4%0.5%3 $5.83 11/30/202237,300 shares $204.03 thousand +9.1%0.4%2.3 $5.47 11/15/202234,200 shares $198.36 thousand -3.1%0.4%1.7 $5.80 10/31/202235,300 shares $211.80 thousand -27.5%0.4%1.1 $6.00 10/15/202248,700 shares $258.11 thousand +10.9%0.6%1.4 $5.30 9/30/202243,900 shares $145.75 thousand -34.1%0.5%1.2 $3.32 9/15/202266,600 shares $279.05 thousand +26.1%0.8%1.3 $4.19 8/31/202252,800 shares $250.80 thousand -39.5%0.6%1 $4.75 8/15/202287,300 shares $467.93 thousand -10.9%1.0%1.6 $5.36 7/31/202298,000 shares $352.80 thousand +2.9%1.1%1.8 $3.60 7/15/202295,200 shares $437.92 thousand +26.8%1.1%1.9 $4.60 6/30/202275,100 shares $450.60 thousand -96.8%9.6%1.5 $6.00 6/15/20222,380,000 shares $1.09 million +10.2%2.3%4.1 $0.46 5/31/20222,160,000 shares $777.82 thousand +4.4%2.0%4.8 $0.36 5/15/20222,070,000 shares $517.29 thousand -0.5%2.0%4.7 $0.25 4/30/20222,080,000 shares $854.88 thousand +20.9%1.9%5.2 $0.41 4/15/20221,720,000 shares $1.03 million +19.4%1.5%4.5 $0.60 3/31/20221,440,000 shares $1.04 million +2.1%1.3%2.8 $0.72 3/15/20221,410,000 shares $913.40 thousand -0.7%1.3%2.7 $0.65 2/28/20221,420,000 shares $1.04 million +13.6%1.3%2.6 $0.73 2/15/20221,250,000 shares $1.13 million -17.2%1.1%2.4 $0.90 1/31/20221,510,000 shares $1.48 million -24.1%1.4%3 $0.98 1/15/20221,990,000 shares $1.99 million +28.4%1.8%3.9 $1.00 12/31/20211,550,000 shares $2.64 million No Change1.4%3.7 $1.70 AVTX Short Interest - Frequently Asked Questions What is Avalo Therapeutics' current short interest? Short interest is the volume of Avalo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 46,900 shares of AVTX short. 0.54% of Avalo Therapeutics' shares are currently sold short. Learn More on Avalo Therapeutics' current short interest. What is a good short interest percentage for Avalo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.54% of Avalo Therapeutics' floating shares are currently sold short. Is Avalo Therapeutics' short interest increasing or decreasing? Avalo Therapeutics saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 46,900 shares, a decline of 45.8% from the previous total of 86,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Avalo Therapeutics' float size? Avalo Therapeutics currently has issued a total of 10,828,000 shares. Some of Avalo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Avalo Therapeutics currently has a public float of 8,610,000 shares. How does Avalo Therapeutics' short interest compare to its competitors? 0.54% of Avalo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avalo Therapeutics: Nuvectis Pharma, Inc. (19.61%), Inhibrx, Inc. (7.16%), ProQR Therapeutics (0.78%), Monopar Therapeutics Inc. (0.86%), Eledon Pharmaceuticals, Inc. (2.77%), Esperion Therapeutics, Inc. (13.54%), Voyager Therapeutics, Inc. (6.14%), Journey Medical Co. (4.40%), DiaMedica Therapeutics Inc. (2.77%), Organigram Holdings Inc. (6.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Avalo Therapeutics stock? Short selling AVTX is an investing strategy that aims to generate trading profit from Avalo Therapeutics as its price is falling. AVTX shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avalo Therapeutics? A short squeeze for Avalo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTX, which in turn drives the price of the stock up even further. How often is Avalo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTX, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Nuvectis Pharma Short Squeeze Inhibrx Short Squeeze ProQR Therapeutics Short Squeeze Monopar Therapeutics Short Squeeze Eledon Pharmaceuticals Short Squeeze Esperion Therapeutics Short Squeeze Voyager Therapeutics Short Squeeze Journey Medical Short Squeeze DiaMedica Therapeutics Short Squeeze Organigram Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVTX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVTX Stock Free AVTX Stock Alerts